Rethinking value construction in biomedicine and healthcare
Rethinking value construction in biomedicine and healthcare
复制标题
DOI：
10.1057/s41292-020-00220-6
复制
发表时间：
2021-01-29
期刊：
影响因子：
1.6
通讯作者：
Prainsack, Barbara
中科院分区：
文献类型：
--
作者：
Datta Burton, Saheli;Kieslich, Katharina;Prainsack, Barbara
尽管长期以来一直试图概念化和衡量生物医学和医疗保健领域的价值，但对于价值是什么，还没有一个统一的定义。相反，因此，价值通常被认为是给定的或以经济术语构建的。在本文中，我们认为，将价值的含义视为给定的，或者回归价值的技术官僚或经济维度，掩盖了医疗保健和生物医学实践中价值构建和操作化的非技术和社会维度。通过对五个生物医学和医疗保健案例的比较研究，我们的目标是揭示使事物对社会有价值的社会经济和政治过程及其影响。我们的观点是，更清楚地了解什么使某些东西有价值（或没有价值）是对生物医学和医疗保健进行社会反省和负责任的评估的第一步。
Despite longstanding attempts to conceptualise and measure value in biomedicine and healthcare, there is no single agreed definition of what value is. Instead, and as such, value is often taken as given or constructed in economic terms. In this paper, we argue that taking the meaning of value as given, or reverting to technocratic or economic dimensions of value, obscures the non-technical and societal dimensions of value construction and operationalisation in healthcare and biomedical practices. Through a comparative study of five cases of biomedicine and healthcare, we aim to bring out the socioeconomic and political processes that make a thing valuable for society and its implications. Our contention is that a clearer understanding of what makes something valuable (or not) is the first step towards what socially reflexive and responsible valuing of biomedicine and healthcare ought to be.